DYAI - DYADIC INTERNATIONAL INC


1.09
-0.030   -2.752%

Share volume: 49,964
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$1.12
-0.03
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024 12-31-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Report Date 05-10-2023 08-09-2023 11-08-2023 03-28-2024 05-14-2024 08-13-2024 11-12-2024 03-26-2025
Total revenue 978.052 K 837.159 K 397.060 K 686.535 K 334.617 K 385.896 K 1.958 M 817.376 K
Cost of revenue 726.918 K 792.944 K 105.869 K 350.118 K 143.955 K 301.956 K 395.894 K 352.819 K
Gross profit 251.134 K 44.215 K 291.191 K 336.417 K 190.662 K 83.940 K 1.562 M 464.557 K
    -82.39% 558.58% 15.53% -43.33% -55.97% 1,760.38% -70.25%  
Operating expenses 2.291 M 2.320 M 1.999 M 2.505 M 2.311 M 2.123 M 1.758 M 1.986 M
Selling general and admin 1.480 M 1.403 M 1.282 M 1.652 M 1.789 M 1.608 M 1.298 M 1.440 M
Research and development 810.566 K 917.552 K 716.351 K 852.797 K 522.723 K 515.629 K 460.241 K 545.660 K
Total expenses 3.018 M 3.113 M 2.105 M 2.855 M 2.316 M 2.127 M 1.764 M 1.995 M
    3.17% -32.40% 35.65% -18.87% -8.19% -17.04% 13.06%  
Operating income -2.039 M -2.276 M -1.708 M -2.168 M -2.126 M -2.043 M -202.614 K -1.530 M
Ebit -2.039 M -2.276 M -1.708 M -2.168 M -2.126 M -2.043 M -202.614 K -1.530 M
Pretax income -956.444 K -2.153 M -1.614 M -2.072 M -2.010 M -2.045 M -203.460 K -1.551 M
    125.10% -25.02% 28.34% -3.00% 1.77% -90.05% 662.25%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -956.444 K -2.153 M -1.614 M -2.072 M 0.000 0.000 0.000 0.000
    -125.10% 25.02% -28.34% 100.00%        
Net income -956.444 K -2.153 M -1.614 M -2.072 M -2.010 M -2.045 M -203.460 K -1.551 M
    -125.10% 25.02% -28.34% 3.00% -1.77% 90.05% -662.25%